Holen Sie sich die Stockscreener-App
45.32
0.60%
0.27
Handel nachbörslich:
45.32
Schlusskurs vom Vortag:
$45.05
Offen:
$45.48
24-Stunden-Volumen:
394.66K
Relative Volume:
0.62
Marktkapitalisierung:
$2.31B
Einnahmen:
$292.09M
Nettoeinkommen (Verlust:
$21.46M
KGV:
110.78
EPS:
0.4091
Netto-Cashflow:
$47.49M
1W Leistung:
-1.22%
1M Leistung:
-1.97%
6M Leistung:
+23.89%
1J Leistung:
+12.96%
1-Tages-Spanne:
$45.21
$46.14
1-Wochen-Bereich:
$43.95
$46.39
52-Wochen-Spanne:
$28.95
$48.75
Vericel Corp Stock (VCEL) Company Profile
Firmenname
Vericel Corp
Sektor
Branche
Telefon
(734) 930-5555
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
45.32 | 2.30B | 292.09M | 21.46M | 47.49M | 0.4091 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-06-20 | Eingeleitet | TD Cowen | Buy |
| 2024-01-25 | Hochstufung | Truist | Hold → Buy |
| 2023-08-08 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-11-09 | Herabstufung | Truist | Buy → Hold |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2021-01-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Eingeleitet | Stephens | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2019-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Needham | Buy → Hold |
| 2018-08-08 | Bestätigt | Needham | Buy |
| 2018-07-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-06 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2018-03-05 | Bestätigt | BTIG Research | Buy |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-03-13 | Bestätigt | Needham | Buy |
| 2016-12-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-09 | Bestätigt | Needham | Buy |
| 2016-04-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Vericel Corp Aktie (VCEL) Neueste Nachrichten
Vericel Corp (VCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vericel Corp (VCEL) Balance Sheet - TradingKey
Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vericel Corp (VCEL) Cash Flow - TradingKey
VCEL|Vericel Corp|Price:45.735|Chg%:+0.685 - TradingKey
TradingKey - TradingKey
Vericel Corporation (VCEL) Stock Forecasts - Yahoo! Finance Canada
Vericel Corporation (ATQP) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Vericel Corp (VCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ETFs Investing in Vericel Corporation Stocks - TradingView
Vericel Corporation (VCEL) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Vericel Corp (NASDAQ:VCEL): Strong Growth Stock With a Bull Flag Breakout Setup - ChartMill
Vericel Corp (NASDAQ:VCEL): An Affordable Growth Stock at a Reasonable Valuation - ChartMill
Vericel stock hits 52-week high at 48.41 USD By Investing.com - Investing.com South Africa
symbol__ Stock Quote Price and Forecast - CNN
VCEL Maintained by Truist Securities -- Price Target Raised to $54.00 - GuruFocus
Vericel stock hits 52-week high at 48.41 USD - Investing.com
Vericel schedules July 30 webcast for second-quarter update - Stock Titan
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 - Yahoo Finance
Vericel Company Profile & Introduction - Moomoo
Is Vericel (NASDAQ:VCEL) Emerging As A Small-Cap Healthcare Story? - Kalkine Media
Vericel stock hits 52-week high at 47.15 USD By Investing.com - Investing.com Nigeria
Vericel stock hits 52-week high at 47.15 USD - Investing.com
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise - Investing.com
VCEL News | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel CMO Jonathan Hopper sells $450,000 in company stock By Investing.com - Investing.com South Africa
Vericel CMO Jonathan Hopper sells $450,000 in company stock - Investing.com
Vericel CFO Joseph Mara sells $223,750 of VCEL stock - Investing.com
Vericel CFO Joseph Mara sells $223,750 of VCEL stock By Investing.com - Investing.com South Africa
Vericel chief legal officer Sean Flynn sells $684,600 in shares - Investing.com
Vericel chief legal officer Sean Flynn sells $684,600 in shares By Investing.com - Investing.com Nigeria
Form 4 Vericel Corp Ord For: 30 June By Investing.com - Investing.com Canada
Vericel (VCEL) accounting officer sells 2,732 shares, exercises options - Stock Titan
Vericel (VCEL) CMO exercises options, sells 10,000 shares under 10b5-1 plan - Stock Titan
Vericel Corporation (VCEL) Slips 2.51%: Support and Resistance Levels in FocusRisk Reversal - dars.gov.et
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests - Yahoo Finance
Form 144 Vericel Corp For: 26 June By Investing.com - Investing.com Nigeria
Vericel stock hits 52-week high at 43.57 USD - Investing.com UK
Vericel stock hits 52-week high at 43.57 USD By Investing.com - Investing.com Nigeria
15,000-Share Option Exercise Reported for Vericel (NASDAQ: VCEL) - Stock Titan
VCEL (NASDAQ) insider sale: Joseph A. Mara sold 5,000 shares for $202,500 - Stock Titan
VCEL proposed share resale and recent insider trades (NASDAQ: VCEL) - Stock Titan
[144] Vericel Corp SEC Filing - Stock Titan
Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech - ChartMill
VCEL Forecast — Price Target — Prediction for 2027 - TradingView
Vericel Corp (VCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VCEL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vericel (VCEL) COO exercises options, sells 10,000 shares under 10b5-1 plan - Stock Titan
Vericel (NASDAQ: VCEL) CLO exercises options and sells 15K shares - Stock Titan
VCEL Technical Analysis & Stock Price Forecast - Intellectia AI
Finanzdaten der Vericel Corp-Aktie (VCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):